These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

458 related items for PubMed ID: 26781439

  • 1. Efficacy and feasibility of ambulatory treatment-based monthly nedaplatin plus S-1 in definitive or salvage concurrent chemoradiotherapy for early, advanced, and relapsed esophageal cancer.
    Yamashita H, Haga A, Takenaka R, Kiritoshi T, Okuma K, Ohtomo K, Nakagawa K.
    Radiat Oncol; 2016 Jan 19; 11():4. PubMed ID: 26781439
    [Abstract] [Full Text] [Related]

  • 2. [Concurrent chemoradiotherapy with nedaplatin and 5-fluorouracil (5-fu) for locally advanced squamous cell carcinoma of the esophagus].
    Kubo N, Morimoto J, Tanaka H, Ohira M, Noda E, Amano R, Inoue T, Yamada N, Yashiro M, Maeda K, Yamashita Y, Muguruma K, Sawada T, Hirakawa K.
    Gan To Kagaku Ryoho; 2009 Nov 19; 36(12):1997-9. PubMed ID: 20037303
    [Abstract] [Full Text] [Related]

  • 3. Prospective non-randomized study of preoperative concurrent platinum plus 5-fluorouracil-based chemoradiotherapy with or without paclitaxel in esophageal cancer patients: long-term follow-up.
    Zemanova M, Petruzelka L, Pazdro A, Kralova D, Smejkal M, Pazdrova G, Honova H.
    Dis Esophagus; 2010 Feb 19; 23(2):160-7. PubMed ID: 19515190
    [Abstract] [Full Text] [Related]

  • 4. Phase I/II trial of chemoradiotherapy with concurrent S-1 and cisplatin for clinical stage II/III esophageal carcinoma (JCOG 0604).
    Tahara M, Fuse N, Mizusawa J, Sato A, Nihei K, Kanato K, Kato K, Yamazaki K, Muro K, Takaishi H, Boku N, Ohtsu A.
    Cancer Sci; 2015 Oct 19; 106(10):1414-20. PubMed ID: 26250827
    [Abstract] [Full Text] [Related]

  • 5. Salvage radiation therapy and chemoradiation therapy for postoperative locoregional recurrence of esophageal cancer.
    Kobayashi R, Yamashita H, Okuma K, Shiraishi K, Ohtomo K, Nakagawa K.
    Dis Esophagus; 2014 Jan 19; 27(1):72-8. PubMed ID: 23551708
    [Abstract] [Full Text] [Related]

  • 6. Neoadjuvant concurrent chemoradiotherapy followed by definitive high-dose radiotherapy or surgery for operable thoracic esophageal carcinoma.
    Murakami M, Kuroda Y, Okamoto Y, Kono K, Yoden E, Kusumi F, Hajiro K, Matsusue S, Takeda H.
    Int J Radiat Oncol Biol Phys; 1998 Mar 15; 40(5):1049-59. PubMed ID: 9539559
    [Abstract] [Full Text] [Related]

  • 7. Single-institute phase I/II trial of alternating chemoradiotherapy with 5-FU and nedaplatin for esophageal carcinoma.
    Kodaira T, Fuwa N, Kamata M, Furutani K, Tachibana H, Yamazaki T.
    Anticancer Res; 2006 Mar 15; 26(1B):471-8. PubMed ID: 16739307
    [Abstract] [Full Text] [Related]

  • 8. [Concurrent chemoradiotherapy (CRT) with S-1 and cisplatin (CDDP) in patients (pts) with locally advanced head and neck cancer (HNC)].
    Tahara M.
    Gan To Kagaku Ryoho; 2006 Jun 15; 33 Suppl 1():167-71. PubMed ID: 16897996
    [Abstract] [Full Text] [Related]

  • 9. Dose escalation study of docetaxel and nedaplatin in patients with relapsed or refractory squamous cell carcinoma of the esophagus pretreated using cisplatin, 5-fluorouracil, and radiation.
    Yoshioka T, Sakayori M, Kato S, Chiba N, Miyazaki S, Nemoto K, Shibata H, Shimodaira H, Ohtsuka K, Kakudo Y, Sakata Y, Ishioka C.
    Int J Clin Oncol; 2006 Dec 15; 11(6):454-60. PubMed ID: 17180514
    [Abstract] [Full Text] [Related]

  • 10. Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for Stage II-III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906).
    Kato K, Muro K, Minashi K, Ohtsu A, Ishikura S, Boku N, Takiuchi H, Komatsu Y, Miyata Y, Fukuda H, Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group (JCOG).
    Int J Radiat Oncol Biol Phys; 2011 Nov 01; 81(3):684-90. PubMed ID: 20932658
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and toxicity of nedaplatin and 5-FU with radiation treatment for advanced esophageal carcinomas.
    Kato H, Fukuchi M, Manda R, Nakajima M, Miyazaki T, Sohda M, Masuda N, Fukai Y, Tsukada K, Kuwano H.
    Anticancer Res; 2003 Nov 01; 23(4):3493-8. PubMed ID: 12926096
    [Abstract] [Full Text] [Related]

  • 12. [Nedaplatin and 5-fluorouracil combined with radiotherapy for advanced esophageal cancer].
    Nakamura T, Ide H, Eguchi R, Hayashi K, Ota M, Narumiya K, Takasaki K, Mitsuhashi M.
    Gan To Kagaku Ryoho; 2003 Jun 01; 30(6):803-7. PubMed ID: 12852347
    [Abstract] [Full Text] [Related]

  • 13. A prospective phase II trial of S-1 and cisplatin-based chemoradiotherapy for locoregionally advanced esophageal cancer.
    Chang H, Shin SK, Cho BC, Lee CG, Kim CB, Kim DJ, Lee JG, Hur J, Lee CY, Bae MK, Kim HR, Lee SK, Park JC, Lee H, Kim HI, Chung H, Cha J, Lee YC, Kim JH.
    Cancer Chemother Pharmacol; 2014 Apr 01; 73(4):665-71. PubMed ID: 24562525
    [Abstract] [Full Text] [Related]

  • 14. Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus.
    Ohtsu A, Boku N, Muro K, Chin K, Muto M, Yoshida S, Satake M, Ishikura S, Ogino T, Miyata Y, Seki S, Kaneko K, Nakamura A.
    J Clin Oncol; 1999 Sep 01; 17(9):2915-21. PubMed ID: 10561371
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of concurrent chemoradiotherapy as a palliative treatment in stage IVB esophageal cancer patients with dysphagia.
    Ikeda E, Kojima T, Kaneko K, Minashi K, Onozawa M, Nihei K, Fuse N, Yano T, Yoshino T, Tahara M, Doi T, Ohtsu A.
    Jpn J Clin Oncol; 2011 Aug 01; 41(8):964-72. PubMed ID: 21742654
    [Abstract] [Full Text] [Related]

  • 16. Outcomes from chemoradiotherapy for patients with esophageal cancer.
    Pantling AZ, Gossage JA, Mamidanna R, Newman G, Robinson A, Manifold DK, Hale PC.
    Dis Esophagus; 2011 Apr 01; 24(3):172-6. PubMed ID: 21073614
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of combined docetaxel and nedaplatin chemotherapy for recurrent esophageal cancer compared with conventional chemotherapy using cisplatin and 5-fluorouracil: a retrospective study.
    Fujita Y, Hiramatsu M, Kawai M, Sumiyoshi K, Nishimura H, Tanigawa N.
    Dis Esophagus; 2008 Apr 01; 21(6):496-501. PubMed ID: 18840134
    [Abstract] [Full Text] [Related]

  • 18. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
    Chang PM, Chen PM, Chu PY, Wang LW, Tai SK, Tsai TL, Huang JL, Wang YF, Chang SY, Yang MH.
    Cancer Chemother Pharmacol; 2008 Dec 01; 63(1):9-17. PubMed ID: 18343925
    [Abstract] [Full Text] [Related]

  • 19. Clinical results of definitive chemoradiotherapy for patients with synchronous head and neck squamous cell carcinoma and esophageal cancer.
    Shinoto M, Shioyama Y, Sasaki T, Nakamura K, Ohura H, Toh Y, Higaki Y, Yamaguchi T, Ohnishi K, Atsumi K, Hirata H, Honda H.
    Am J Clin Oncol; 2011 Aug 01; 34(4):362-6. PubMed ID: 20686402
    [Abstract] [Full Text] [Related]

  • 20. [Complete response in a case of advanced esophageal cancer treated by combined chemotherapy of TS-1 and CDDP with radiotherapy].
    Nakarai K, Iwase H, Shimada M, Iyo T, Kaida S, Indou T, Doi R, Okeya M.
    Gan To Kagaku Ryoho; 2004 Feb 01; 31(2):229-31. PubMed ID: 14997757
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.